Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08EES
|
||||
Former ID |
DIB006142
|
||||
Drug Name |
XR-5000
|
||||
Synonyms |
DACA; SN-22995
|
||||
Indication | Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] | Phase 2 | [526364] | ||
Company |
Xenova
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1c2c(C(=O)NCCN(C)C)cccc2cc2c1cccc2.Cl.Cl
|
||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Modulator | [526364] | |
DNA topoisomerase II | Target Info | Modulator | [526364] | ||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.